BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belbasis L, Bellou V, Evangelou E, Ioannidis JPA, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. The Lancet Neurology 2015;14:263-73. [DOI: 10.1016/s1474-4422(14)70267-4] [Cited by in Crossref: 300] [Cited by in F6Publishing: 164] [Article Influence: 42.9] [Reference Citation Analysis]
Number Citing Articles
1 Wojtak K, Perales-Puchalt A, Weiner DB. Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth. Vaccines (Basel) 2019;7:E44. [PMID: 31137606 DOI: 10.3390/vaccines7020044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kadowaki A, Quintana FJ. The Gut-CNS Axis in Multiple Sclerosis. Trends Neurosci 2020;43:622-34. [PMID: 32650957 DOI: 10.1016/j.tins.2020.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
3 Jeong GH, Lee KH, Kim JY, Eisenhut M, Kronbichler A, van der Vliet HJ, Hong SH, Shin JI, Gamerith G. Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis. J Clin Med 2019;8:E819. [PMID: 31181789 DOI: 10.3390/jcm8060819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 't Hart BA, Kap YS. An essential role of virus-infected B cells in the marmoset experimental autoimmune encephalomyelitis model. Mult Scler J Exp Transl Clin 2017;3:2055217317690184. [PMID: 28607749 DOI: 10.1177/2055217317690184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
5 Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Front Immunol 2021;12:757302. [PMID: 34790199 DOI: 10.3389/fimmu.2021.757302] [Reference Citation Analysis]
6 Brabaharan S, Veettil SK, Kaiser JE, Raja Rao VR, Wattanayingcharoenchai R, Maharajan M, Insin P, Talungchit P, Anothaisintawee T, Thakkinstian A, Chaiyakunapruk N. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies. JAMA Netw Open 2022;5:e2143730. [PMID: 35029663 DOI: 10.1001/jamanetworkopen.2021.43730] [Reference Citation Analysis]
7 Martinez B, Peplow PV. MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. Neural Regen Res 2020;15:606-19. [PMID: 31638082 DOI: 10.4103/1673-5374.266905] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
8 Bazargan-Hejazi S, Dehghan K, Edwards C, Mohammadi N, Attar S, Sahraian MA, Eskandarieh S. The health burden of non-communicable neurological disorders in the USA between 1990 and 2017. Brain Commun 2020;2:fcaa097. [PMID: 32954341 DOI: 10.1093/braincomms/fcaa097] [Reference Citation Analysis]
9 Giannakou K, Evangelou E, Yiallouros P, Christophi CA, Middleton N, Papatheodorou E, Papatheodorou SI. Risk factors for gestational diabetes: An umbrella review of meta-analyses of observational studies.PLoS One. 2019;14:e0215372. [PMID: 31002708 DOI: 10.1371/journal.pone.0215372] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
10 Song J, Westerlind H, McKay KA, Almqvist C, Stridh P, Kockum I, Hillert J, Manouchehrinia A. Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study. J Neurol 2019;266:481-6. [PMID: 30578428 DOI: 10.1007/s00415-018-9163-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Enzmann G, Adelfio R, Godel A, Haghayegh Jahromi N, Tietz S, Burgener SS, Deutsch U, Wekerle H, Benarafa C, Engelhardt B. The Genetic Background of Mice Influences the Effects of Cigarette Smoke on Onset and Severity of Experimental Autoimmune Encephalomyelitis. Int J Mol Sci 2019;20:E1433. [PMID: 30901861 DOI: 10.3390/ijms20061433] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Bühring J, Hecker M, Fitzner B, Zettl UK. Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis. Aging Dis 2021;12:1272-86. [PMID: 34341708 DOI: 10.14336/AD.2021.0106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zang ST, Wu QJ, Li XY, Gao C, Liu YS, Jiang YT, Zhang JY, Sun H, Chang Q, Zhao YH. Long-term PM2.5 exposure and various health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies. Sci Total Environ 2021;812:152381. [PMID: 34914980 DOI: 10.1016/j.scitotenv.2021.152381] [Reference Citation Analysis]
14 Nally FK, De Santi C, McCoy CE. Nanomodulation of Macrophages in Multiple Sclerosis. Cells 2019;8:E543. [PMID: 31195710 DOI: 10.3390/cells8060543] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
15 Oliver D, Reilly TJ, Baccaredda Boy O, Petros N, Davies C, Borgwardt S, McGuire P, Fusar-Poli P. What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors. Schizophr Bull 2020;46:110-20. [PMID: 31219164 DOI: 10.1093/schbul/sbz039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 42.0] [Reference Citation Analysis]
16 Trepanowski JF, Ioannidis JPA. Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How. Adv Nutr 2018;9:367-77. [PMID: 30032218 DOI: 10.1093/advances/nmy014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
17 Friess J, Hecker M, Roch L, Koczan D, Fitzner B, Angerer IC, Schröder I, Flechtner K, Thiesen HJ, Winkelmann A, Zettl UK. Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. Sci Rep 2017;7:42087. [PMID: 28155899 DOI: 10.1038/srep42087] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
18 Zhang TN, Wu QJ, Liu YS, Lv JL, Sun H, Chang Q, Liu CF, Zhao YH. Environmental Risk Factors and Congenital Heart Disease: An Umbrella Review of 165 Systematic Reviews and Meta-Analyses With More Than 120 Million Participants. Front Cardiovasc Med 2021;8:640729. [PMID: 33791351 DOI: 10.3389/fcvm.2021.640729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gerdes LA, Janoschka C, Eveslage M, Mannig B, Wirth T, Schulte-Mecklenbeck A, Lauks S, Glau L, Gross CC, Tolosa E, Flierl-Hecht A, Ertl-Wagner B, Barkhof F, Meuth SG, Kümpfel T, Wiendl H, Hohlfeld R, Klotz L. Immune signatures of prodromal multiple sclerosis in monozygotic twins. Proc Natl Acad Sci U S A 2020;117:21546-56. [PMID: 32817525 DOI: 10.1073/pnas.2003339117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 De Luca C, Virtuoso A, Maggio N, Papa M. Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases. Int J Mol Sci 2017;18:E2128. [PMID: 29023416 DOI: 10.3390/ijms18102128] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
21 Hayashi F, Isobe N, Cossu D, Yokoyama K, Sakoda A, Matsushita T, Hattori N, Kira JI. Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis. J Neuroimmunol 2021;360:577701. [PMID: 34507015 DOI: 10.1016/j.jneuroim.2021.577701] [Reference Citation Analysis]
22 Lam T, VoPham T, Munger KL, Laden F, Hart JE. Long-term effects of latitude, ambient temperature, and ultraviolet radiation on the incidence of multiple sclerosis in two cohorts of US women. Environ Epidemiol 2020;4:e0105. [PMID: 32903352 DOI: 10.1097/EE9.0000000000000105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Morandi E, Tarlinton RE, Gran B. Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages. Front Immunol 2015;6:647. [PMID: 26734011 DOI: 10.3389/fimmu.2015.00647] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
24 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
25 Machado MO, Veronese N, Sanches M, Stubbs B, Koyanagi A, Thompson T, Tzoulaki I, Solmi M, Vancampfort D, Schuch FB, Maes M, Fava GA, Ioannidis JPA, Carvalho AF. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. BMC Med 2018;16:112. [PMID: 30025524 DOI: 10.1186/s12916-018-1101-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
26 Deleidi M, Jäggle M, Rubino G. Immune aging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci 2015;9:172. [PMID: 26089771 DOI: 10.3389/fnins.2015.00172] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 18.6] [Reference Citation Analysis]
27 Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, Steptoe A, Whooley MA, Otte C. Comorbid depression in medical diseases. Nat Rev Dis Primers 2020;6:69. [PMID: 32820163 DOI: 10.1038/s41572-020-0200-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 12.5] [Reference Citation Analysis]
28 Hou WH, Li CY, Chang HH, Sun Y, Tsai CC. A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus. J Epidemiol 2017;27:235-41. [PMID: 28142047 DOI: 10.1016/j.je.2016.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
29 Fugl A, Andersen CL. Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract 2019;20:62. [PMID: 31088382 DOI: 10.1186/s12875-019-0954-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
30 Manuel Escobar J, Cortese M, Edan G, Freedman MS, Hartung HP, Montalbán X, Sandbrink R, Radü EW, Barkhof F, Wicklein EM, Kappos L, Ascherio A, Munger KL. Body mass index as a predictor of MS activity and progression among participants in BENEFIT. Mult Scler 2022;:13524585211061861. [PMID: 34994579 DOI: 10.1177/13524585211061861] [Reference Citation Analysis]
31 Arango C, Dragioti E, Solmi M, Cortese S, Domschke K, Murray RM, Jones PB, Uher R, Carvalho AF, Reichenberg A, Shin JI, Andreassen OA, Correll CU, Fusar-Poli P. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry 2021;20:417-36. [PMID: 34505386 DOI: 10.1002/wps.20894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med 2016;14:147. [PMID: 27677312 DOI: 10.1186/s12916-016-0692-5] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 15.3] [Reference Citation Analysis]
33 Rosso M, Kimbrough DJ, Gonzalez CT, Glanz BI, Healy BC, Rocca MA, Filippi M, Weiner H, Chitnis T. Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients. Mult Scler J Exp Transl Clin 2019;5:2055217319828400. [PMID: 30828461 DOI: 10.1177/2055217319828400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, Giovannoni G, Hartung HP, Perron H. Human Endogenous Retroviruses in Neurological Diseases. Trends Mol Med 2018;24:379-94. [PMID: 29551251 DOI: 10.1016/j.molmed.2018.02.007] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 25.8] [Reference Citation Analysis]
35 Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities. Mol Neurobiol 2017;54:3911-23. [PMID: 28455696 DOI: 10.1007/s12035-017-0530-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
36 Catalá-López F, Hutton B, Driver JA, Page MJ, Ridao M, Valderas JM, Alonso-Arroyo A, Forés-Martos J, Martínez S, Gènova-Maleras R, Macías-Saint-Gerons D, Crespo-Facorro B, Vieta E, Valencia A, Tabarés-Seisdedos R. Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies. Syst Rev 2017;6:69. [PMID: 28376926 DOI: 10.1186/s13643-017-0466-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
37 Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry 2018;17:49-66. [PMID: 29352556 DOI: 10.1002/wps.20490] [Cited by in Crossref: 191] [Cited by in F6Publishing: 178] [Article Influence: 47.8] [Reference Citation Analysis]
38 Mohammed EM. Environmental Influencers, MicroRNA, and Multiple Sclerosis. J Cent Nerv Syst Dis 2020;12:1179573519894955. [PMID: 32009827 DOI: 10.1177/1179573519894955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
39 Liu FH, Liu C, Gong TT, Gao S, Sun H, Jiang YT, Zhang JY, Zhang M, Gao C, Li XY, Zhao YH, Wu QJ. Dietary Inflammatory Index and Health Outcomes: An Umbrella Review of Systematic Review and Meta-Analyses of Observational Studies. Front Nutr 2021;8:647122. [PMID: 34095187 DOI: 10.3389/fnut.2021.647122] [Reference Citation Analysis]
40 Mouchet J, Bégaud B. Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database. Drug Saf 2018;41:767-74. [PMID: 29560597 DOI: 10.1007/s40264-018-0652-4] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Mentis AA, Dardiotis E, Efthymiou V, Chrousos GP. Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews. BMC Med 2021;19:6. [PMID: 33435977 DOI: 10.1186/s12916-020-01873-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
42 Riemann-Lorenz K, Eilers M, von Geldern G, Schulz KH, Köpke S, Heesen C. Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program. PLoS One 2016;11:e0165246. [PMID: 27764237 DOI: 10.1371/journal.pone.0165246] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
43 Bashamakh LF, Alsharif SM, Wayyani LA, Alghamdi AE, Fatani GM, Alnajashi HA, Alshamrani FJ. Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis. Neurosciences (Riyadh) 2019;24:278-83. [PMID: 31872806 DOI: 10.17712/nsj.2019.4.20190027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Najafi F, Jaafarpour M, Sayehmiri K, Khajavikhan J. An Evaluation of Acupressure on the Sanyinjiao (SP6) and Hugo (LI4) Points on the Pain Severity and Length of Labor: A Systematic Review and Meta-analysis Study. Iran J Nurs Midwifery Res 2018;23:1-7. [PMID: 29344038 DOI: 10.4103/ijnmr.IJNMR_184_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
45 Bellucci G, Rinaldi V, Buscarinu MC, Reniè R, Bigi R, Pellicciari G, Morena E, Romano C, Marrone A, Mechelli R, Salvetti M, Ristori G. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Front Immunol 2021;12:755333. [PMID: 34646278 DOI: 10.3389/fimmu.2021.755333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 North K, Marx Delaney M, Bose C, Lee ACC, Vesel L, Adair L, Semrau K. The effect of milk type and fortification on the growth of low-birthweight infants: An umbrella review of systematic reviews and meta-analyses. Matern Child Nutr 2021;17:e13176. [PMID: 33733580 DOI: 10.1111/mcn.13176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Blaschek A, Huppke P, Kümpfel T, Müller-Felber W, Rostasy K. [Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated]. Nervenarzt 2017;88:1377-84. [PMID: 29038883 DOI: 10.1007/s00115-017-0422-z] [Reference Citation Analysis]
48 Matveeva O, Bogie JFJ, Hendriks JJA, Linker RA, Haghikia A, Kleinewietfeld M. Western lifestyle and immunopathology of multiple sclerosis. Ann N Y Acad Sci 2018;1417:71-86. [PMID: 29377214 DOI: 10.1111/nyas.13583] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
49 Sestili C, Grazina I, La Torre G. HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis. Hum Vaccin Immunother 2021;17:2273-8. [PMID: 30260264 DOI: 10.1080/21645515.2018.1528835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
50 Levet S, Charvet B, Bertin A, Deschaumes A, Perron H, Hober D. Human Endogenous Retroviruses and Type 1 Diabetes. Curr Diab Rep 2019;19:141. [PMID: 31754894 DOI: 10.1007/s11892-019-1256-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
51 Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. J Neurol 2015;262:2713-21. [PMID: 26429571 DOI: 10.1007/s00415-015-7902-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
52 Maver A, Lavtar P, Ristić S, Stopinšek S, Simčič S, Hočevar K, Sepčić J, Drulović J, Pekmezović T, Novaković I, Alenka H, Rudolf G, Šega S, Starčević-Čizmarević N, Palandačić A, Zamolo G, Kapović M, Likar T, Peterlin B. Identification of rare genetic variation of NLRP1 gene in familial multiple sclerosis. Sci Rep 2017;7:3715. [PMID: 28623311 DOI: 10.1038/s41598-017-03536-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
53 Kim JY, Steingroever J, Lee KH, Oh J, Choi MJ, Lee J, Larkins NG, Schaefer F, Hong SH, Jeong GH, Shin JI, Kronbichler A. Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-Analyses. J Clin Med 2020;9:E394. [PMID: 32024136 DOI: 10.3390/jcm9020394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Cossu D, Yokoyama K, Sechi LA, Otsubo S, Tomizawa Y, Momotani E, Hattori N. Humoral response against host-mimetic homologous epitopes of Mycobacterium avium subsp. paratuberculosis in Japanese multiple sclerosis patients. Sci Rep 2016;6:29227. [PMID: 27356622 DOI: 10.1038/srep29227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
55 Forbes JD, Chen CY, Knox NC, Marrie RA, El-Gabalawy H, de Kievit T, Alfa M, Bernstein CN, Van Domselaar G. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome 2018;6:221. [PMID: 30545401 DOI: 10.1186/s40168-018-0603-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 18.0] [Reference Citation Analysis]
56 Dehghani A, Khoramkish M, Shahsavari Isfahani S. Challenges in the Daily Living Activities of Patients with Multiple Sclerosis: A Qualitative Content Analysis. Int J Community Based Nurs Midwifery 2019;7:201-10. [PMID: 31341919 DOI: 10.30476/IJCBNM.2019.44995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Kim JY, Lee KH, Eisenhut M, van der Vliet HJ, Kronbichler A, Jeong GH, Shin JI, Gamerith G. Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Cancers (Basel) 2019;11:E1801. [PMID: 31731818 DOI: 10.3390/cancers11111801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
58 Hecker M, Bühring J, Fitzner B, Rommer PS, Zettl UK. Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis. Biomolecules 2021;11:1510. [PMID: 34680143 DOI: 10.3390/biom11101510] [Reference Citation Analysis]
59 Riccio P, Rossano R, Larocca M, Trotta V, Mennella I, Vitaglione P, Ettorre M, Graverini A, De Santis A, Di Monte E, Coniglio MG. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med (Maywood) 2016;241:620-35. [PMID: 26785711 DOI: 10.1177/1535370215618462] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
60 Abu-Rub M, Miller RH. Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination. Brain Sci 2018;8:E111. [PMID: 29914096 DOI: 10.3390/brainsci8060111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
61 van Leeuwen MT, Luu S, Gurney H, Brown MR, Webber K, Pearson SA, Hunt L, Vajdic CM. Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews. BMJ Open 2018;8:e021064. [PMID: 29950466 DOI: 10.1136/bmjopen-2017-021064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Chen W, Li Y, Guo L, Zhang C, Tang S. An umbrella review of systematic reviews and meta-analyses of observational investigations of obstructive sleep apnea and health outcomes. Sleep Breath 2021. [PMID: 33893906 DOI: 10.1007/s11325-021-02384-2] [Reference Citation Analysis]
63 Chen M, Tang TC, He TH, Du YJ, Qin D, Zheng H. Management of haemorrhoids: protocol of an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e035287. [PMID: 32213524 DOI: 10.1136/bmjopen-2019-035287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 't Hart BA. Primate autoimmune disease models; lost for translation? Clin Transl Immunology 2016;5:e122. [PMID: 28435673 DOI: 10.1038/cti.2016.82] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Doshi A, Chataway J. Multiple sclerosis, a treatable disease. Clin Med (Lond) 2016;16:s53-9. [PMID: 27956442 DOI: 10.7861/clinmedicine.16-6-s53] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
66 Moghaddam VK, Dickerson AS, Bazrafshan E, Seyedhasani SN, Najafi F, Hadei M, Momeni J, Moradi G, Sarmadi M. Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data. BMC Neurol 2021;21:145. [PMID: 33794796 DOI: 10.1186/s12883-021-02170-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ruprecht K, Wildemann B, Jarius S. Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature. J Neurol 2018;265:239-52. [PMID: 29098417 DOI: 10.1007/s00415-017-8656-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
68 Nielsen AS. Advances in the management of relapsing-remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12). Degener Neurol Neuromuscul Dis 2015;5:51-61. [PMID: 32669912 DOI: 10.2147/DNND.S68723] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Jacobs BM, Giovannoni G, Cuzick J, Dobson R. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler 2020;26:1281-97. [PMID: 32202208 DOI: 10.1177/1352458520907901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
70 Binzer S, McKay KA, Brenner P, Hillert J, Manouchehrinia A. Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study. Neurology 2019;93:e2216-23. [PMID: 31704791 DOI: 10.1212/WNL.0000000000008617] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
71 El-Muzaini H, Akhtar S, Alroughani R. A matched case-control study of risk factors associated with multiple sclerosis in Kuwait. BMC Neurol 2020;20:64. [PMID: 32085743 DOI: 10.1186/s12883-020-01635-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
72 Jakimovski D, Weinstock-Guttman B, Gandhi S, Guan Y, Hagemeier J, Ramasamy DP, Fuchs TA, Browne RW, Bergsland N, Dwyer MG, Ramanathan M, Zivadinov R. Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study. J Neurol 2019;266:866-75. [PMID: 30758665 DOI: 10.1007/s00415-019-09208-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
73 Safaei HA, Eftekhari SM, Aliomrani M. Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model. Metab Brain Dis 2021. [PMID: 34342813 DOI: 10.1007/s11011-021-00802-8] [Reference Citation Analysis]
74 Feige J, Moser T, Bieler L, Schwenker K, Hauer L, Sellner J. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats. Nutrients 2020;12:E783. [PMID: 32188044 DOI: 10.3390/nu12030783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
75 Kasiri N, Rahmati M, Ahmadi L, Eskandari N. The significant impact of apigenin on different aspects of autoimmune disease. Inflammopharmacology 2018;26:1359-73. [PMID: 30229507 DOI: 10.1007/s10787-018-0531-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
76 Zhang F, Wang H, Huang L, Zhang H. Therapeutic effects of exercise interventions for patients with chronic kidney disease: protocol for an overview of systematic reviews and meta-analyses of clinical trials. BMJ Open 2021;11:e043011. [PMID: 33574151 DOI: 10.1136/bmjopen-2020-043011] [Reference Citation Analysis]
77 Rojas-Rueda D, Morales-Zamora E, Alsufyani WA, Herbst CH, AlBalawi SM, Alsukait R, Alomran M. Environmental Risk Factors and Health: An Umbrella Review of Meta-Analyses. Int J Environ Res Public Health 2021;18:E704. [PMID: 33467516 DOI: 10.3390/ijerph18020704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
78 Dagan A, Gringouz I, Kliers I, Segal G. Disability Progression in Multiple Sclerosis Is Affected by the Emergence of Comorbid Arterial Hypertension. J Clin Neurol 2016;12:345-50. [PMID: 27273922 DOI: 10.3988/jcn.2016.12.3.345] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
79 Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation. Acta Neurol Scand 2017;136:606-16. [PMID: 28542724 DOI: 10.1111/ane.12775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
80 Jovel J, O'keefe S, Patterson J, Bording-Jorgensen M, Wang W, Mason AL, Warren KG, Wong GK. Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA. Front Cell Infect Microbiol 2016;6:198. [PMID: 28111617 DOI: 10.3389/fcimb.2016.00198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
81 Carstensen M, Christensen T, Stilund M, Møller HJ, Petersen EL, Petersen T. Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis. Immunol Cell Biol 2020;98:549-62. [PMID: 32253768 DOI: 10.1111/imcb.12337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
82 Hecker M, Boxberger N, Illner N, Fitzner B, Schröder I, Winkelmann A, Dudesek A, Meister S, Koczan D, Lorenz P, Thiesen HJ, Zettl UK. A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene. PLoS Genet 2019;15:e1007961. [PMID: 30730892 DOI: 10.1371/journal.pgen.1007961] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 Jin S, Li YF, Qin D, Luo DQ, Guo H, Gao XH, Yue L, Zheng H. Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses. BMJ Open 2019;9:e027778. [PMID: 30898835 DOI: 10.1136/bmjopen-2018-027778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
84 Doshi A, Chataway J. Multiple sclerosis, a treatable disease . Clin Med (Lond) 2017;17:530-6. [PMID: 29196354 DOI: 10.7861/clinmedicine.17-6-530] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
85 Amini P, Almasi-Hashiani A, Sahraian MA, Najafi M, Eskandarieh S. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol 2021;21:235. [PMID: 34167483 DOI: 10.1186/s12883-021-02281-x] [Reference Citation Analysis]
86 Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CM, Machado-Vieira R, Ribeiro TL, Silva JC, Sales PM, Quevedo J, Oertel-Knöchel V, Vieta E, González-Pinto A, Berk M, Carvalho AF. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med 2015;13:289. [PMID: 26621529 DOI: 10.1186/s12916-015-0529-7] [Cited by in Crossref: 149] [Cited by in F6Publishing: 128] [Article Influence: 21.3] [Reference Citation Analysis]
87 Xia Z, Steele SU, Bakshi A, Clarkson SR, White CC, Schindler MK, Nair G, Dewey BE, Price LR, Ohayon J, Chibnik LB, Cortese IC, De Jager PL, Reich DS. Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members. JAMA Neurol 2017;74:293-300. [PMID: 28114441 DOI: 10.1001/jamaneurol.2016.5056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
88 Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Oh H, Choi EK, Shin JI, Giovannucci EL, Gamerith G. Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. Adv Nutr 2020;11:1134-49. [PMID: 32488249 DOI: 10.1093/advances/nmaa055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Chou IJ, Wang HS, Whitehouse WP, Constantinescu CS. Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices. Curr Neurol Neurosci Rep 2016;16:68. [PMID: 27271748 DOI: 10.1007/s11910-016-0663-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
90 Dolei A, Ibba G, Piu C, Serra C. Expression of HERV Genes as Possible Biomarker and Target in Neurodegenerative Diseases. Int J Mol Sci 2019;20:E3706. [PMID: 31362360 DOI: 10.3390/ijms20153706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
91 Tian Z, Song Y, Yao Y, Guo J, Gong Z, Wang Z. Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke. Front Genet 2020;11:646. [PMID: 32719717 DOI: 10.3389/fgene.2020.00646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Liu YS, Wu QJ, Lv JL, Jiang YT, Sun H, Xia Y, Chang Q, Zhao YH. Dietary Carbohydrate and Diverse Health Outcomes: Umbrella Review of 30 Systematic Reviews and Meta-Analyses of 281 Observational Studies. Front Nutr 2021;8:670411. [PMID: 33996880 DOI: 10.3389/fnut.2021.670411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Gharaylou Z, Sahraian MA, Hadjighassem M, Kohanpour M, Doosti R, Nahardani S, Moghadasi AN. Widespread Disruptions of White Matter in Familial Multiple Sclerosis: DTI and NODDI Study. Front Neurol 2021;12:678245. [PMID: 34484098 DOI: 10.3389/fneur.2021.678245] [Reference Citation Analysis]
94 Dehghani A, Dehghan Nayeri N, Ebadi A. Features of Coping with Disease in Iranian Multiple Sclerosis Patients: a Qualitative Study. J Caring Sci 2018;7:35-40. [PMID: 29637055 DOI: 10.15171/jcs.2018.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
95 Ammitzbøll C, Börnsen L, Petersen ER, Oturai AB, Søndergaard HB, Grandjean P, Sellebjerg F. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. J Neuroimmunol 2019;330:90-5. [PMID: 30852181 DOI: 10.1016/j.jneuroim.2019.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Abrahamyan S, Eberspächer B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Grüter T, Tackenberg B, Paul F, Then-Bergh F, Kümpfel T, Weber F, Stangel M, Bayas A, Wildemann B, Heesen C, Zettl U, Warnke C, Antony G, Hessler N, Wiendl H, Bittner S, Hemmer B, Gold R, Salmen A, Ruprecht K; German Competence Network Multiple Sclerosis (KKNMS)., Other members of the KKNMS that acted as collaborators in this study. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis. J Neurol Neurosurg Psychiatry 2020;91:681-6. [PMID: 32371533 DOI: 10.1136/jnnp-2020-322941] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
97 Paraboschi EM, Cardamone G, Soldà G, Duga S, Asselta R. Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions. Front Genet 2018;9:647. [PMID: 30619471 DOI: 10.3389/fgene.2018.00647] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
98 Hočevar K, Ristić S, Peterlin B. Pharmacogenomics of Multiple Sclerosis: A Systematic Review. Front Neurol 2019;10:134. [PMID: 30863357 DOI: 10.3389/fneur.2019.00134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
99 Pérez-Pérez S, Domínguez-Mozo MI, Alonso-Gómez A, Medina S, Villarrubia N, Fernández-Velasco JI, García-Martínez MÁ, García-Calvo E, Estévez H, Costa-Frossard L, Alvarez-Cermeño JC, Luque-Garcia JL, Arroyo R, Villar LM, Alvarez-Lafuente R. Acetate correlates with disability and immune response in multiple sclerosis. PeerJ 2020;8:e10220. [PMID: 33240608 DOI: 10.7717/peerj.10220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
100 Halawani AT, Zeidan ZA, Kareem AM, Alharthi AA, Almalki HA. Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia. A matched case control study. Saudi Med J 2018;39:808-14. [PMID: 30106419 DOI: 10.15537/smj.2018.8.22864] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
101 Yakhdani MF, Jalili M, Salehi-Abargouei A, Mirzaei M, Rahimdel A, Ebrahimi AA. Interaction of MS prevalence, radon gas concentration, and patient nutrition: a case-control study. Sci Rep 2021;11:17906. [PMID: 34504114 DOI: 10.1038/s41598-021-96816-4] [Reference Citation Analysis]
102 Brown C. Aetiology: Neighbourhood watch. Nature 2016;540:S4-6. [PMID: 27902678 DOI: 10.1038/540S4a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Huang YC, Chien WC, Chung CH, Chang HA, Kao YC, Wan FJ, Huang SH, Chung RJ, Wang RS, Wang BL, Tzeng NS, Sun CA. Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population. Neuropsychiatr Dis Treat 2021;17:587-604. [PMID: 33654401 DOI: 10.2147/NDT.S268360] [Reference Citation Analysis]
104 Yokoyama K, Cossu D, Hoshino Y, Tomizawa Y, Momotani E, Hattori N. Anti-Mycobacterial Antibodies in Paired Cerebrospinal Fluid and Serum Samples from Japanese Patients with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder. J Clin Med 2018;7:E522. [PMID: 30544526 DOI: 10.3390/jcm7120522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
105 Hassani A, Khan G. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis? Front Immunol 2019;10:695. [PMID: 31001286 DOI: 10.3389/fimmu.2019.00695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
106 Mescheriakova JY, van Nierop GP, van der Eijk AA, Kreft KL, Hintzen RQ. EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution. Neurol Neuroimmunol Neuroinflamm 2020;7:e872. [PMID: 32796079 DOI: 10.1212/NXI.0000000000000872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Boyko AN, Boyko OV. Cladribine tablets' potential role as a key example of selective immune reconstitution therapy in multiple sclerosis. Degener Neurol Neuromuscul Dis 2018;8:35-44. [PMID: 30050387 DOI: 10.2147/DNND.S161450] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Choi BY, Jung JW, Suh SW. The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis. Int J Mol Sci 2017;18:E2070. [PMID: 28956834 DOI: 10.3390/ijms18102070] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
109 Boziki MK, Kesidou E, Theotokis P, Mentis AA, Karafoulidou E, Melnikov M, Sviridova A, Rogovski V, Boyko A, Grigoriadis N. Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know. Brain Sci 2020;10:E234. [PMID: 32295236 DOI: 10.3390/brainsci10040234] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
110 Jeanjean M, Bind MA, Roux J, Ongagna JC, de Sèze J, Bard D, Leray E. Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses. Environ Res 2018;163:43-52. [PMID: 29426027 DOI: 10.1016/j.envres.2018.01.040] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
111 Cortes-Figueiredo F, Nielsen NM, Stenager E, Paul F, Hallas J, Kristensen KB. Retinoids are not linked to risk of multiple sclerosis: A Danish nationwide cohort study. Eur J Neurol 2022;29:247-56. [PMID: 34536255 DOI: 10.1111/ene.15116] [Reference Citation Analysis]
112 Chountoulesi M, Demetzos C. Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System. Brain Sci 2020;10:E338. [PMID: 32498357 DOI: 10.3390/brainsci10060338] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
113 Wang YF, He DD, Liang HW, Yang D, Yue H, Zhang XM, Wang R, Li B, Yang HX, Liu Y, Chen Y, Duan YX, Zhang CY, Chen X, Fu J. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis. Clin Exp Immunol 2017;189:120-6. [PMID: 28253538 DOI: 10.1111/cei.12954] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
114 Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadié M, Foretová L, Staines A, Mack TM, de Sanjosé S, Vyse TJ, Padyukov L, Monnereau A, Arslan AA, Moore A, Brooks-Wilson AR, Novak AJ, Glimelius B, Birmann BM, Link BK, Stewart C, Vajdic CM, Haioun C, Magnani C, Conti DV, Cox DG, Casabonne D, Albanes D, Kane E, Roman E, Muzi G, Salles G, Giles GG, Adami HO, Ghesquières H, De Vivo I, Clavel J, Cerhan JR, Spinelli JJ, Hofmann J, Vijai J, Curtin K, Costenbader KH, Onel K, Offit K, Teras LR, Morton L, Conde L, Miligi L, Melbye M, Ennas MG, Liebow M, Purdue MP, Glenn M, Southey MC, Din M, Rothman N, Camp NJ, Wong Doo N, Becker N, Pradhan N, Bracci PM, Boffetta P, Vineis P, Brennan P, Kraft P, Lan Q, Severson RK, Vermeulen RCH, Milne RL, Kaaks R, Travis RC, Weinstein SJ, Chanock SJ, Ansell SM, Slager SL, Zheng T, Zhang Y, Benavente Y, Taub Z, Madireddy L, Gourraud PA, Oksenberg JR, Cozen W, Hjalgrim H, Khankhanian P. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genet Epidemiol 2019;43:844-63. [PMID: 31407831 DOI: 10.1002/gepi.22242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
115 Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Martin-Hirsch P, Tsilidis KK. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477. [PMID: 28246088 DOI: 10.1136/bmj.j477] [Cited by in Crossref: 283] [Cited by in F6Publishing: 262] [Article Influence: 56.6] [Reference Citation Analysis]
116 Pust GEA, Untiedt B, Randerath J, Barabasch A, Köpke S, Rahn AC, Hansen H, Heesen C. Exploring Adherence to First-Line and Second-Line Immunotherapies in Multiple Sclerosis: An Interview Study. Int J MS Care 2020;22:219-25. [PMID: 33177958 DOI: 10.7224/1537-2073.2018-068] [Reference Citation Analysis]
117 Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology 2017;89:1330-7. [PMID: 28855411 DOI: 10.1212/WNL.0000000000004412] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 7.2] [Reference Citation Analysis]
118 Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 2018;13:e0192109. [PMID: 29394264 DOI: 10.1371/journal.pone.0192109] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
119 Zuluaga MI, Otero-Romero S, Rovira A, Perez-Hoyos S, Arrambide G, Negrotto L, Galán I, Río J, Comabella M, Nos C, Arévalo MJ, Vidal-Jordana A, Castilló J, Rodríguez B, Midaglia L, Mulero P, Mitjana R, Auger C, Sastre-Garriga J, Montalban X, Tintoré M. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis. Neurology 2019;92:e1507-16. [PMID: 30824557 DOI: 10.1212/WNL.0000000000007178] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 7.7] [Reference Citation Analysis]
120 Menegatti S, Bianchi E, Rogge L. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses. Front Immunol 2019;10:382. [PMID: 30941119 DOI: 10.3389/fimmu.2019.00382] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
121 Roch L, Hecker M, Friess J, Angerer IC, Koczan D, Fitzner B, Schröder I, Flechtner K, Thiesen HJ, Meister S, Winkelmann A, Zettl UK. High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. Mol Neurobiol 2017;54:5511-25. [PMID: 27631876 DOI: 10.1007/s12035-016-0075-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
122 van den Berg R, Hoogenraad CC, Hintzen RQ. Axonal transport deficits in multiple sclerosis: spiraling into the abyss. Acta Neuropathol 2017;134:1-14. [PMID: 28315956 DOI: 10.1007/s00401-017-1697-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
123 Albatineh AN, Alroughani R, Al-Temaimi R. Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis. Int J MS Care 2020;22:233-8. [PMID: 33177960 DOI: 10.7224/1537-2073.2019-054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Fan Y, Zhang J. Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Microbiol 2019;10:740. [PMID: 31040833 DOI: 10.3389/fmicb.2019.00740] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
125 Pernice S, Pennisi M, Romano G, Maglione A, Cutrupi S, Pappalardo F, Balbo G, Beccuti M, Cordero F, Calogero RA. A computational approach based on the colored Petri net formalism for studying multiple sclerosis. BMC Bioinformatics 2019;20:623. [PMID: 31822261 DOI: 10.1186/s12859-019-3196-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
126 Van Leeuwen MT, Luu S, Gurney H, Brown MR, Pearson SA, Webber K, Hunt L, Hong S, Delaney GP, Vajdic CM. Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews. JNCI Cancer Spectr 2020;4:pkaa076. [PMID: 33392444 DOI: 10.1093/jncics/pkaa076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
127 Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, Demurtas J, Mosina A, Kurotschka P, Thompson T, Cortese S, Shin JI, Fusar-Poli P. Risk and Protective Factors for Personality Disorders: An Umbrella Review of Published Meta-Analyses of Case-Control and Cohort Studies. Front Psychiatry 2021;12:679379. [PMID: 34552513 DOI: 10.3389/fpsyt.2021.679379] [Reference Citation Analysis]
128 Maglione A, Zuccalà M, Tosi M, Clerico M, Rolla S. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis. Genes (Basel) 2021;12:1181. [PMID: 34440354 DOI: 10.3390/genes12081181] [Reference Citation Analysis]
129 Gandhi F, Jhaveri S, Avanthika C, Singh A, Jain N, Gulraiz A, Shah P, Nasir F. Impact of Vitamin D Supplementation on Multiple Sclerosis. Cureus 2021;13:e18487. [PMID: 34754649 DOI: 10.7759/cureus.18487] [Reference Citation Analysis]
130 Ahmed M, Mir R, Shakra M, Al Fardan S. Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging. Mult Scler Int 2019;2019:7460213. [PMID: 31885922 DOI: 10.1155/2019/7460213] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Manouchehri N, Zhang Y, Salter A, Hussain RZ, Hartung HP, Hemmer B, Linker R, Segal BM, Cutter G, Stüve O. Clinical trials in multiple sclerosis: potential future trial designs. Ther Adv Neurol Disord 2019;12:1756286419847095. [PMID: 31205492 DOI: 10.1177/1756286419847095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Maglione A, Rolla S, Mercanti SF, Cutrupi S, Clerico M. The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View. Cells 2019;8:E1280. [PMID: 31635066 DOI: 10.3390/cells8101280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
133 Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology 2018;154:204-19. [PMID: 29513402 DOI: 10.1111/imm.12922] [Cited by in Crossref: 228] [Cited by in F6Publishing: 230] [Article Influence: 57.0] [Reference Citation Analysis]
134 Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med 2020;9:7964-78. [PMID: 32924316 DOI: 10.1002/cam4.3428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
135 Patel CJ. Analytical Complexity in Detection of Gene Variant-by-Environment Exposure Interactions in High-Throughput Genomic and Exposomic Research. Curr Environ Health Rep 2016;3:64-72. [PMID: 26809563 DOI: 10.1007/s40572-016-0080-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
136 Monti MC, Guido D, Montomoli C, Sardu C, Sanna A, Pretti S, Lorefice L, Marrosu MG, Valera P, Cocco E. Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia. PLoS One 2016;11:e0163313. [PMID: 27669512 DOI: 10.1371/journal.pone.0163313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
137 Braliou GG, Pantavou KG, Kontou PI, Bagos PG. Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis. Int J Mol Sci 2015;16:12368-81. [PMID: 26039238 DOI: 10.3390/ijms160612368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
138 Krajnc N, Bsteh G, Berger T. Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review. Front Neurol 2021;12:666868. [PMID: 34512500 DOI: 10.3389/fneur.2021.666868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Koretsi V, Eliades T, Papageorgiou SN. Oral Interventions for Obstructive Sleep Apnea. Dtsch Arztebl Int 2018;115:200-7. [PMID: 29642990 DOI: 10.3238/arztebl.2018.0200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
140 Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, Rezaei M, Fakhri N. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Mult Scler Relat Disord 2021;57:103441. [PMID: 34896874 DOI: 10.1016/j.msard.2021.103441] [Reference Citation Analysis]
141 Dehghan M, Ghaedi-Heidari F. Environmental Risk Factors for Multiple Sclerosis: A Case-control Study in Kerman, Iran. Iran J Nurs Midwifery Res 2018;23:431-6. [PMID: 30386392 DOI: 10.4103/ijnmr.IJNMR_192_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Dinu M, Pagliai G, Angelino D, Rosi A, Dall'Asta M, Bresciani L, Ferraris C, Guglielmetti M, Godos J, Del Bo' C, Nucci D, Meroni E, Landini L, Martini D, Sofi F. Effects of Popular Diets on Anthropometric and Cardiometabolic Parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Adv Nutr 2020;11:815-33. [PMID: 32059053 DOI: 10.1093/advances/nmaa006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 32.0] [Reference Citation Analysis]
143 GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:269-85. [PMID: 30679040 DOI: 10.1016/S1474-4422(18)30443-5] [Cited by in Crossref: 280] [Cited by in F6Publishing: 119] [Article Influence: 93.3] [Reference Citation Analysis]
144 Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS One 2018;13:e0194127. [PMID: 29558518 DOI: 10.1371/journal.pone.0194127] [Cited by in Crossref: 148] [Cited by in F6Publishing: 137] [Article Influence: 37.0] [Reference Citation Analysis]
145 Xuan J, Ji Z, Wang B, Zeng X, Chen R, He Y, Rao P, Wu P, Shi G. Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome. Front Immunol 2020;11:590444. [PMID: 33193425 DOI: 10.3389/fimmu.2020.590444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 De Luca C, Colangelo AM, Alberghina L, Papa M. Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System. Front Cell Neurosci 2018;12:459. [PMID: 30534057 DOI: 10.3389/fncel.2018.00459] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
147 Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol 2018;18:325-39. [PMID: 29292391 DOI: 10.1038/nri.2017.143] [Cited by in Crossref: 196] [Cited by in F6Publishing: 172] [Article Influence: 49.0] [Reference Citation Analysis]
148 Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Mitra A, Terzidou V, Bennett P, Martin-Hirsch P, Tsilidis KK, Kyrgiou M. Obesity and gynaecological and obstetric conditions: umbrella review of the literature. BMJ 2017;359:j4511. [PMID: 29074629 DOI: 10.1136/bmj.j4511] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 11.2] [Reference Citation Analysis]
149 Vidmar L, Maver A, Drulović J, Sepčić J, Novaković I, Ristič S, Šega S, Peterlin B. Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes. Sci Rep 2019;9:9171. [PMID: 31235738 DOI: 10.1038/s41598-019-45598-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
150 Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin and Autoimmunity. Front Immunol 2018;9:73. [PMID: 29483903 DOI: 10.3389/fimmu.2018.00073] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 12.5] [Reference Citation Analysis]
151 Geraldes R, Esiri MM, DeLuca GC, Palace J. Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis. Brain Pathol 2017;27:707-22. [PMID: 27864848 DOI: 10.1111/bpa.12460] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
152 Vandebergh M, Goris A. Smoking and multiple sclerosis risk: a Mendelian randomization study. J Neurol 2020;267:3083-91. [PMID: 32529581 DOI: 10.1007/s00415-020-09980-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
153 Yang TT, Yin H, Liu PJ, Niu TT, Wang ZY, He Y, Yuan P, Zhang WW, Xu BL, Liu GZ. A preliminary study of association of cigarette smoking with risk of neuromyelitis optica spectrum disorder. Medicine (Baltimore) 2021;100:e27234. [PMID: 34664866 DOI: 10.1097/MD.0000000000027234] [Reference Citation Analysis]
154 Rothhammer V, Quintana FJ. Environmental control of autoimmune inflammation in the central nervous system. Curr Opin Immunol 2016;43:46-53. [PMID: 27710839 DOI: 10.1016/j.coi.2016.09.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
155 Taghipour A, Rostami A, Esfandyari S, Aghapour S, Nicoletti A, Gasser RB. "Begging the Question"-Does Toxocara Infection/Exposure Associate with Multiple Sclerosis-Risk? Pathogens 2020;9:E938. [PMID: 33187271 DOI: 10.3390/pathogens9110938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
156 Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72:30-43. [PMID: 28488692 DOI: 10.1038/ejcn.2017.58] [Cited by in Crossref: 323] [Cited by in F6Publishing: 280] [Article Influence: 64.6] [Reference Citation Analysis]
157 Dendrou CA, McVean G, Fugger L. Neuroinflammation - using big data to inform clinical practice. Nat Rev Neurol 2016;12:685-98. [PMID: 27857124 DOI: 10.1038/nrneurol.2016.171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
158 Laribi B, Shekarabi M, Zarnani AH, Ghaffarpour M, Marzban M. Differential serostatus of Epstein-Barr virus in Iranian MS patients with various clinical patterns. Med J Islam Repub Iran 2018;32:118. [PMID: 30815413 DOI: 10.14196/mjiri.32.118] [Reference Citation Analysis]
159 Liu S, Rezende RM, Moreira TG, Tankou SK, Cox LM, Wu M, Song A, Dhang FH, Wei Z, Costamagna G, Weiner HL. Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila. Cell Host Microbe 2019;26:779-794.e8. [PMID: 31784260 DOI: 10.1016/j.chom.2019.10.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
160 Xu Y, Hiyoshi A, Smith KA, Piehl F, Olsson T, Fall K, Montgomery S. Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings. JAMA Netw Open 2021;4:e2124932. [PMID: 34633426 DOI: 10.1001/jamanetworkopen.2021.24932] [Reference Citation Analysis]
161 Arslan B, Arslan GA, Tuncer A, Karabudak R, Dinçel AS. Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Front Neurol 2021;12:716195. [PMID: 34526962 DOI: 10.3389/fneur.2021.716195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Forbes JD, Van Domselaar G, Bernstein CN. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol 2016;7:1081. [PMID: 27462309 DOI: 10.3389/fmicb.2016.01081] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 29.7] [Reference Citation Analysis]
163 Tengvall K, Huang J, Hellström C, Kammer P, Biström M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundström P, Nilsson P, Waterboer T, Olsson T, Kockum I. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc Natl Acad Sci U S A 2019;116:16955-60. [PMID: 31375628 DOI: 10.1073/pnas.1902623116] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
164 Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015;15:545-58. [PMID: 26250739 DOI: 10.1038/nri3871] [Cited by in Crossref: 932] [Cited by in F6Publishing: 902] [Article Influence: 133.1] [Reference Citation Analysis]
165 Ivashynka A, Leone MA, Barizzone N, Cucovici A, Cantello R, Vecchio D, Zuccalà M, Pizzino A, Copetti M, D'alfonso S, Fontana A. The impact of lifetime coffee and tea loads on Multiple Sclerosis severity. Clinical Nutrition ESPEN 2022;47:199-205. [DOI: 10.1016/j.clnesp.2021.12.014] [Reference Citation Analysis]
166 Ünsal MA, Manukyan NY, IŞik N, Dİreskenelİ GS. Assessment of IL-7RA T244I Polymorphism as a Risk Factor of Multiple Sclerosis in Turkish Population. Noro Psikiyatr Ars 2020;57:280-2. [PMID: 33354118 DOI: 10.29399/npa.23437] [Reference Citation Analysis]
167 Ptaszek B, Teległów A, Adamiak J, Głodzik J, Podsiadło S, Mucha D, Marchewka J, Halski T, Mucha D. Effect of Whole-Body Cryotherapy on Morphological, Rheological and Biochemical Indices of Blood in People with Multiple Sclerosis. J Clin Med 2021;10:2833. [PMID: 34198961 DOI: 10.3390/jcm10132833] [Reference Citation Analysis]
168 Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis. Front Immunol 2019;10:1374. [PMID: 31258540 DOI: 10.3389/fimmu.2019.01374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
169 Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol 2019;6:1905-22. [PMID: 31392849 DOI: 10.1002/acn3.50862] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
170 Janiaud P, Agarwal A, Tzoulaki I, Theodoratou E, Tsilidis KK, Evangelou E, Ioannidis JPA. Validity of observational evidence on putative risk and protective factors: appraisal of 3744 meta-analyses on 57 topics. BMC Med 2021;19:157. [PMID: 34225716 DOI: 10.1186/s12916-021-02020-6] [Reference Citation Analysis]
171 Kim TL, Jeong GH, Yang JW, Lee KH, Kronbichler A, van der Vliet HJ, Grosso G, Galvano F, Aune D, Kim JY, Veronese N, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, Cho E, de Rezende LFM, Giovannucci EL, Shin JI, Gamerith G. Tea Consumption and Risk of Cancer: An Umbrella Review and Meta-Analysis of Observational Studies. Adv Nutr 2020;11:1437-52. [PMID: 32667980 DOI: 10.1093/advances/nmaa077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
172 Anaya JM, Ramirez-Santana C, Alzate MA, Molano-Gonzalez N, Rojas-Villarraga A. The Autoimmune Ecology. Front Immunol 2016;7:139. [PMID: 27199979 DOI: 10.3389/fimmu.2016.00139] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
173 Pazhouhandeh M, Sahraian MA, Siadat SD, Fateh A, Vaziri F, Tabrizi F, Ajorloo F, Arshadi AK, Fatemi E, Piri Gavgani S, Mahboudi F, Rahimi Jamnani F. A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients. Clin Exp Immunol 2018;192:18-32. [PMID: 29194580 DOI: 10.1111/cei.13087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
174 Papatheodorou SI, Evangelou E. Umbrella Reviews: What They Are and Why We Need Them. Methods Mol Biol 2022;2345:135-46. [PMID: 34550588 DOI: 10.1007/978-1-0716-1566-9_8] [Reference Citation Analysis]
175 Persson R, Lee S, Yood MU, Wagner M, Minton N, Niemcryk S, Lindholm A, Evans A, Jick S. Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries. J Neurol 2019;266:1095-106. [PMID: 30778708 DOI: 10.1007/s00415-019-09238-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
176 Zhao T, Markevych I, Janßen C, Nowak D, Steckling-Muschack N, Heinrich J. Ozone exposure and health effects: a protocol for an umbrella review and effect-specific systematic maps. BMJ Open 2020;10:e034854. [PMID: 32792426 DOI: 10.1136/bmjopen-2019-034854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]